Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Not Yet Recruiting

Risk-adapted Therapeutic Strategy in +1q NDMM

NCT07045168

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma

NCT07090954

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Shanghai Fourth People's Hospital Affiliated with Tongji University Shanghai, China

The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, China

View Trial Details

Not Yet Recruiting

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

NCT06580223

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

NCT07070934

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

NCT07070960

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

NCT07040189

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
Locations: LMU Klinikum Munich, Bavaria, Germany

Universitätsklinikum Regensburg Regensburg, Bavaria, Germany

Universitätsklinikum Würzburg Würzburg, Bavaria, Germany

View Trial Details

Not Yet Recruiting

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

NCT07018271

Conditions: Agranulocytosis, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

NCT07015021

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Carfilzomib, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

NCT06931704

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CHU Angers Angers, France

CH Côte Basque Bayonne, France

CHU Besançon Besançon, France

CHU Caen Caen, France

View all 36 locations

View Trial Details

Not Yet Recruiting

Multi-center Screening for Serum M Protein

NCT06750965

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions